In recent years, there have been major advances in the field of ATTR amyloidosis. Amongst an existing environment of change and optimism in this field, our members decided to found a UK-based patient group dedicated to the interests of people in the UK with ATTR amyloidosis.
The new UKATPA group will focus specifically on ATTR amyloidosis, and aim to:
• Provide support and information for patients with ATTR amyloidosis
• Involve patients in all aspects of management and research
• Work closely with the amyloidosis specialist physicians at the National Amyloidosis Centre (NAC) to promote interdisciplinary communication with local doctors treating ATTR patients throughout the UK
Join here to be Friends of UKATPA
About Amyloidosis UK
In recent years, there have been major advances in the field of ATTR amyloidosis. Amongst an existing environment of change and optimism in this field, our members decided to found a UK-based patient group dedicated to the interests of people in the UK with ATTR amyloidosis.
The new Amyloidosis UK group will focus specifically on ATTR amyloidosis, and aim to:
• Provide support and information for patients with ATTR amyloidosis
• Involve patients in all aspects of management and research
• Work closely with the amyloidosis specialist physicians at the National Amyloidosis Centre (NAC) to promote interdisciplinary communication with local doctors treating ATTR patients throughout the UK
Join here to be Friends of Amyloidosis UK
Our long-term objectives include:
- Enhancing clinical research into ATTR amyloidosis
- Facilitating patient participation in clinical trials of new drugs for ATTR amyloidosis
- Expediting the drug approval processes
- Ensuring appropriate access for all UK ATTR amyloidosis patients when new drugs receive licensing approval
If you are interested in being a part of the ATTR Amyloidosis Patients’ Association, please complete this contact form.
Our long-term objectives include:
- Enhancing clinical research into ATTR amyloidosis
- Facilitating patient participation in clinical trials of new drugs for ATTR amyloidosis
- Expediting the drug approval processes
- Ensuring appropriate access for all UK ATTR amyloidosis patients when new drugs receive licensing approval
If you are interested in being a part of Amyloidosis UK, please complete this contact form.